The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Dihexa Peptide: Complete Guide to Synaptogenesis (2026) Frontiers Crosstalk of kidney and brain in diabetes related cognitive impairment and therapeutic strategies Diabetic kidney disease (DKD) is usually a clinical diagnosis in a patient with long standing diabetes (>10 years) with albuminuria and or reduced estimated glomerular filtration rate (eGFR) in the absence of signs or Brain peptides in Alzheimer's disease pathophysiology and therapeutic advances Cell and Tissue Research Springer Nature Link